Comparative Pharmacology
Head-to-head clinical analysis: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE versus PROCHLORPERAZINE MALEATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE versus PROCHLORPERAZINE MALEATE.
PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE vs PROCHLORPERAZINE MALEATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Perphenazine is a phenothiazine antipsychotic that blocks postsynaptic dopamine D2 receptors in the mesolimbic system, with additional antagonism at serotonin 5-HT2, alpha-1 adrenergic, histamine H1, and muscarinic M1 receptors. Amitriptyline is a tricyclic antidepressant that inhibits serotonin and norepinephrine reuptake, also antagonizing histamine H1, alpha-1 adrenergic, and muscarinic M1 receptors.
Prochlorperazine is a phenothiazine antipsychotic that primarily antagonizes dopamine D2 receptors in the chemoreceptor trigger zone (CTZ) and central nervous system. It also has anticholinergic and antiemetic effects through blockade of histamine H1 and muscarinic M1 receptors.
Oral: Perphenazine 2-4 mg with amitriptyline 10-50 mg, administered 3-4 times daily. Maximum daily dose: perphenazine 24 mg, amitriptyline 150 mg.
5-10 mg orally 3-4 times daily; or 25 mg rectally twice daily; or 5-10 mg intramuscularly every 3-4 hours up to 40 mg/day; or 2.5-10 mg intravenously slowly at 2.5 mg/min, maximum 20 mg/day.
None Documented
None Documented
Perphenazine: ~9-12 hours (range 8-20 h). Amitriptyline: ~15-24 hours (range 10-50 h). Clinical context: Steady-state reached in 3-10 days; amitriptyline's active metabolite nortriptyline has T½ ~18-35 h.
Terminal elimination half-life is approximately 6-8 hours in adults, but may extend up to 12-15 hours after chronic dosing or in hepatic impairment.
Perphenazine: renal (0.5-2% unchanged), hepatic metabolism and biliary/fecal elimination (major). Amitriptyline: renal (<5% unchanged, 30-50% as metabolites), biliary/fecal (significant). Combined: ~70-80% renal (metabolites), ~20-30% fecal.
Primarily renal (70-80% as metabolites, <1% unchanged); fecal/biliary excretion accounts for 20-30% via enterohepatic circulation.
Category A/B
Category A/B
Typical Antipsychotic
Typical Antipsychotic / Antiemetic